TTK Healthcare (BOM:507747) Piotroski F-Score: 4 (As of Jul. 04, 2026) — 33% Below Median


BOM:507747 TTK Healthcare Ltd BOM:507747
72 GF Score
Price ₹920.00
GF Value ₹1,452.52
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is TTK Healthcare Piotroski F-Score?

TTK Healthcare BOM:507747 +1.47% 72 Piotroski F-Score is 4 as of Jul. 04, 2026, which is 33% below its 10-year median of 6.00. GuruFocus rates BOM:507747 with a GF Score™ of 72/100 and a GF Value™ of ₹1,452.52 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 981 Drug Manufacturers companies, TTK Healthcare ranks worse than 60.86% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

TTK Healthcare has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for TTK Healthcare's Piotroski F-Score or its related term are showing as below:

BOM:507747' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 6   Max: 8
Current: 4

During the past 13 years, the highest Piotroski F-Score of TTK Healthcare was 8. The lowest was 4. And the median was 6.

TTK Healthcare  (BOM:507747) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


TTK Healthcare Piotroski F-Score Related Terms


TTK Healthcare Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for TTK Healthcare's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TTK Healthcare Piotroski F-Score Chart

TTK Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.00 6.00 5.00 4.00 4.00

TTK Healthcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 0.00 0.00 0.00 4.00

BOM:507747 vs LLY, JNJ, ABBV: Piotroski F-Score Comparison

For the Drug Manufacturers - General subindustry, TTK Healthcare's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TTK Healthcare Piotroski F-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TTK Healthcare's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where TTK Healthcare's Piotroski F-Score falls into.


BOM:507747
72GF Score
TTK Healthcare Ltd BOM:507747
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was ₹657 Mil.
Cash Flow from Operations was ₹-211 Mil.
Revenue was ₹8,544 Mil.
Gross Profit was ₹4,481 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was (12811.867 + 13287.425) / 2 = ₹13049.646 Mil.
Total Assets at the begining of this year (Mar25) was ₹12,812 Mil.
Long-Term Debt & Capital Lease Obligation was ₹20 Mil.
Total Current Assets was ₹12,179 Mil.
Total Current Liabilities was ₹2,062 Mil.
Net Income was ₹817 Mil.

Revenue was ₹7,976 Mil.
Gross Profit was ₹4,258 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was (12062.998 + 12811.867) / 2 = ₹12437.4325 Mil.
Total Assets at the begining of last year (Mar24) was ₹12,063 Mil.
Long-Term Debt & Capital Lease Obligation was ₹18 Mil.
Total Current Assets was ₹11,039 Mil.
Total Current Liabilities was ₹2,109 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

TTK Healthcare's current Net Income (TTM) was 657. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

TTK Healthcare's current Cash Flow from Operations (TTM) was -211. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=656.805/12811.867
=0.05126536

ROA (Last Year)=Net Income/Total Assets (Mar24)
=816.569/12062.998
=0.06769204

TTK Healthcare's return on assets of this year was 0.05126536. TTK Healthcare's return on assets of last year was 0.06769204. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

TTK Healthcare's current Net Income (TTM) was 657. TTK Healthcare's current Cash Flow from Operations (TTM) was -211. ==> -211 <= 657 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=19.792/13049.646
=0.00151667

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=17.728/12437.4325
=0.00142537

TTK Healthcare's gearing of this year was 0.00151667. TTK Healthcare's gearing of last year was 0.00142537. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=12179.003/2062.313
=5.90550658

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=11038.918/2109.231
=5.23362211

TTK Healthcare's current ratio of this year was 5.90550658. TTK Healthcare's current ratio of last year was 5.23362211. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

TTK Healthcare's number of shares in issue this year was 14.13. TTK Healthcare's number of shares in issue last year was 14.13. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=4481.424/8543.771
=0.52452529

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=4258.085/7976.276
=0.53384374

TTK Healthcare's gross margin of this year was 0.52452529. TTK Healthcare's gross margin of last year was 0.53384374. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=8543.771/12811.867
=0.66686385

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=7976.276/12062.998
=0.66121838

TTK Healthcare's asset turnover of this year was 0.66686385. TTK Healthcare's asset turnover of last year was 0.66121838. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+0+0+0+0+1+1+0+1
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

TTK Healthcare has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 4 mean?
TTK Healthcare (BOM:507747) has a Piotroski F-Score of 4 as of Jul. 04, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on TTK Healthcare and its competitors. This is 33% below median its historical median of 6.00. Over the past decade, TTK Healthcare's Piotroski F-Score has ranged from 4.00 to 8.00. According to the industry distribution chart, TTK Healthcare ranks #597 out of 981 companies in the Drug Manufacturers industry, placing it in the top 60.9%.
Is TTK Healthcare's Piotroski F-Score too high?
TTK Healthcare's current Piotroski F-Score of 4 is 33% below median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 8.00. The Drug Manufacturers industry median Piotroski F-Score is 5.00. TTK Healthcare's value of 4 is 20% below this industry median. Based on the distribution chart, TTK Healthcare ranks #597 out of 981 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, TTK Healthcare has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does TTK Healthcare's Piotroski F-Score compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, TTK Healthcare ranks #597 out of 981 companies for Piotroski F-Score. This places TTK Healthcare in the lower half of its industry. The industry median Piotroski F-Score is 5.00. TTK Healthcare's value of 4 is 20% below this benchmark. Historically, TTK Healthcare's own Piotroski F-Score has ranged from 4.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, TTK Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Drug Manufacturers company?
The median Piotroski F-Score among Drug Manufacturers companies is 5.00, based on 981 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TTK Healthcare's current Piotroski F-Score of 4 is 20% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on TTK Healthcare and its competitors. For the Drug Manufacturers industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TTK Healthcare's current Piotroski F-Score is 4, which is 33% below median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TTK Healthcare stock overvalued right now?
Based on GuruFocus' analysis, TTK Healthcare (BOM:507747) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹1,452.52, compared to a current price of ₹920.00 — trading 36.7% below its estimated fair value. The current Piotroski F-Score is 4, which is 33% below median its 10-year median of 6.00 and 20% below the Drug Manufacturers industry median of 5.00. TTK Healthcare's overall GF Score™ is 72/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For TTK Healthcare (BOM:507747), the current Piotroski F-Score is 4 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TTK Healthcare (BOM:507747) Overvalued in 2026?

Based on GuruFocus' analysis, TTK Healthcare stock appears to be undervalued. The current stock price of ₹920.00 is trading 36.7% below its estimated GF Value™ of ₹1,452.52. GuruFocus considers TTK Healthcare to be Significantly Undervalued.

Key valuation signals for BOM:507747:

  • Piotroski F-Score: 4 (33% below median its 10-year median of 6.00)
  • GF Value™: ₹1,452.52 vs. price of ₹920.00 (36.7% below fair value)
  • GF Score™: 72/100 with 1 warning sign
  • Industry Position: 20% below the Drug Manufacturers median (#597 of 981)

No single metric tells the full story. See the BOM:507747 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


TTK Healthcare Business Description

Other Exchanges TTKHLTCARE:India
Address No. 6, Cathedral Road, Chennai, TN, IND, 600 086
TTK Healthcare Ltd is an Indian pharmaceutical company. The company's operating segment includes Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods Division, and Others. Its Animal Welfare segment includes products for both Human and Veterinary use. The Consumer Products comprises of marketing and distribution of Woodwards's Gripe Water, EVA Range of Cosmetics, Good Home range of Scrubbers, Air Fresheners and others. Protective Devices comprises of manufacturing and marketing of Male Contraceptives and other allied products. It generates maximum revenue from the Pharmaceuticals segment. Geographically, it derives a majority of revenue from India.
72GF Score

Get the complete analysis for BOM:507747

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹920.00
Price
₹1,452.52
GF Value